Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Linda Kaplan who wrote (6928)	6/3/1999 8:59:00 PM
From: biodoc	Read Replies (1) \| Respond to of 7041

The FDA lately has been very sensitive to the issue of drugs recalled after approval. They have received criticism from consumer groups and Congress regarding recent withdrawals of approval. It has led to an increased sensitivity to potential safety issues when drugs are approved. However, the specific drug mentioned in the article has no relevance to vasomax and its situation. Biodoc (Note--I have a short position in ZONA)